Allianz Asset Management
PAHC icon

Allianz Asset Management’s Phibro Animal Health PAHC Stock Holding History

Allianz Asset Management’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-61,407
Closed -$1.31M – 2221
2025
Q1 		$1.31M Sell
61,407
-1,667
-3% -$37.3K ﹤0.01% 1612
2024
Q4 		$1.32M Buy
63,074
+48,074
+320% +$1.11M ﹤0.01% 1565
2024
Q3 		$338K Buy
+15,000
New +$290K ﹤0.01% 1963
2021
Q2 		– Sell
-12,015
Closed -$293K – 2452
2021
Q1 		$293K Buy
+12,015
New +$271K ﹤0.01% 2046
2020
Q1 		– Sell
-38,187
Closed -$948K – 2688
2019
Q4 		$948K Sell
38,187
-18,847
-33% -$437K ﹤0.01% 2226
2019
Q3 		$1.22M Buy
57,034
+6,823
+14% +$187K ﹤0.01% 2041
2019
Q2 		$1.59M Buy
50,211
+27,207
+118% +$853K ﹤0.01% 1960
2019
Q1 		$759K Sell
23,004
-43,398
-65% -$1.35M ﹤0.01% 2191
2018
Q4 		$2.13M Sell
66,402
-10,859
-14% -$410K ﹤0.01% 1748
2018
Q3 		$3.31M Sell
77,261
-12,264
-14% -$579K ﹤0.01% 1740
2018
Q2 		$4.12M Sell
89,525
-20,079
-18% -$889K ﹤0.01% 1614
2018
Q1 		$4.35M Buy
109,604
+31,694
+41% +$1.17M ﹤0.01% 1592
2017
Q4 		$2.61M Sell
77,910
-31,020
-28% -$1.1M ﹤0.01% 1917
2017
Q3 		$4.04M Buy
108,930
+2,465
+2% +$92.6K ﹤0.01% 1722
2017
Q2 		$4M Sell
106,465
-670
-0.6% -$21.9K ﹤0.01% 1691
2017
Q1 		$3.01M Buy
107,135
+77,550
+262% +$2.19M ﹤0.01% 1843
2016
Q4 		$867K Buy
29,585
+2,630
+10% +$71.8K ﹤0.01% 2247
2016
Q3 		$712K Buy
+26,955
New +$610K ﹤0.01% 2294
2016
Q1 		– Sell
-595,787
Closed -$18M – 2560
2015
Q4 		$18M Sell
595,787
-83,805
-12% -$2.69M 0.02% 802
2015
Q3 		$21.5M Buy
679,592
+18,539
+3% +$677K 0.03% 679
2015
Q2 		$25.7M Sell
661,053
-233,092
-26% -$8.04M 0.03% 681
2015
Q1 		$31.7M Buy
894,145
+12,769
+1% +$411K 0.04% 528
2014
Q4 		$27.8M Buy
881,376
+580,473
+193% +$16.1M 0.03% 596
2014
Q3 		$6.74M Buy
+300,903
New +$6.03M 0.01% 972

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CM
CastleKnight Management New York $7.38B AUM 133.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Allianz Asset Management's PAHC Position: Q2 2025 in Review

Allianz Asset Management sold out of Phibro Animal Health (PAHC) in Q2 2025, closing a stake of 61,407 shares — an estimated $1.31M sold.

Allianz Asset Management first reported a position in PAHC in Q3 2014 and held it in 24 quarters. The position peaked at $31.7M in Q1 2015. 194 funds tracked by Wall St. Rank hold PAHC as of Q2 2025.

  • Allianz Asset Management reported no remaining Phibro Animal Health position as of Q2 2025 after selling out during the quarter.
  • Allianz Asset Management sold 61,407 Phibro Animal Health shares in Q2 2025, an estimated $1.31M.
  • Allianz Asset Management first reported a position in Phibro Animal Health in Q3 2014 and held it in 24 quarters.
  • Allianz Asset Management's Phibro Animal Health position peaked at $31.7M in Q1 2015.
  • 194 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2025.

Based on Allianz Asset Management's 13F filing for Q2 2025, filed 28 Jul 2025.